NDC 66869-564

SEGLENTIS

Celecoxib And Tramadol Hydrochloride

SEGLENTIS is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Kowa Pharmaceuticals America, Inc.. The primary component is Celecoxib; Tramadol Hydrochloride.

• Product ID: 66869-564_cf2c8436-a9f4-473c-e053-2a95a90a1123
• NDC: 66869-564
• Product Type: Human Prescription Drug
• Proprietary Name: SEGLENTIS
• Generic Name: Celecoxib And Tramadol Hydrochloride
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2022-01-01
• Marketing Category: NDA /
• Application Number: NDA213426
• Labeler Name: Kowa Pharmaceuticals America, Inc.
• Substance Name: CELECOXIB; TRAMADOL HYDROCHLORIDE
• Active Ingredient Strength: 56 mg/1; mg/1
• Pharm Classes: Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
• DEA Schedule: CIV
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 66869-564-90

1 BOTTLE, PLASTIC in 1 CARTON (66869-564-90) > 90 TABLET in 1 BOTTLE, PLASTIC

• Marketing Start Date: 2022-01-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details